Ryvu Therapeutics Summarizes 2023 Fiscal Year and Provides Corporate Update ...Middle East

News by : (PR Newswire) -
Total operating revenues for the full year 2023 were $16.3M, compared to $15.8M for the same period in 2022. As of March 7, 2024, Ryvu's cash position was $57.2M, excluding the first tranche of €8M in venture debt from the EIB, expected imminently. Together with other already secured...

Hence then, the article about ryvu therapeutics summarizes 2023 fiscal year and provides corporate update was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Ryvu Therapeutics Summarizes 2023 Fiscal Year and Provides Corporate Update )

Last updated :

Also on site :

Most Viewed News
جديد الاخبار